Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/105795
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFalcon Neyra, Lola-
dc.contributor.authorBenmarzouk-Hidalgo, Omar J.-
dc.contributor.authorMadrid, Lola-
dc.contributor.authorNoguera Julian, Antoni-
dc.contributor.authorFortuny Guasch, Claudia-
dc.contributor.authorNeth, Olaf-
dc.contributor.authorLópez Cortés, Luis F.-
dc.date.accessioned2017-01-18T16:35:40Z-
dc.date.available2017-01-18T16:35:40Z-
dc.date.issued2015-03-
dc.identifier.issn0025-7974-
dc.identifier.urihttp://hdl.handle.net/2445/105795-
dc.description.abstractThis is a cross-sectional study of 15 aviremic chronic HIV-infected children revealing no differences in immune activation (IA; HLA-DRCD38 CD4 and CD8 T cells, and sCD14) and microbial translocation (MT; lipopolysaccharides (LPS) and 16S rDNA) among HIV-infected patients under combined antiretroviral treatment (cART; n = 10) or ritonavir-boosted protease inhibitor monotherapy (mtPI/rtv; n = 5). In both cases, IA and MT were lower in healthy control children (n = 32). This observational study suggests that ritonavir boosted protease inhibitor monotherapy (mtPI/rtv) is not associated with an increased state of IA or MT as compared with children receiving cART.-
dc.format.extent4 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherLippincott, Williams & Wilkins. Wolters Kluwer Health-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1097/MD.0000000000000521-
dc.relation.ispartofMedicine, 2015, vol. 94, num. 11, p. e521-
dc.relation.urihttps://doi.org/10.1097/MD.0000000000000521-
dc.rightscc-by (c) Falcon-Neyra, L. et al., 2015-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es-
dc.sourceArticles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques)-
dc.subject.classificationInfants-
dc.subject.classificationInfeccions per VIH-
dc.subject.classificationAntiretrovirals-
dc.subject.classificationInhibidors enzimàtics-
dc.subject.otherChildren-
dc.subject.otherHIV infections-
dc.subject.otherAntiretroviral agents-
dc.subject.otherEnzyme inhibitors-
dc.titleNo differences of immune activation and microbial translocation among HIV-infected children receiving combined antiretroviral therapy or protease inhibitor monotherapy.-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec660358-
dc.date.updated2017-01-18T16:35:41Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid25789946-
Appears in Collections:Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques)
Articles publicats en revistes (ISGlobal)

Files in This Item:
File Description SizeFormat 
660358.pdf150.54 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons